Analysis of glutamine dependency in non-small cell lung cancer

References

• Tennant DA, Durán RV, Gottlieb E. Targeting metabolic transformation for cancer therapy. Nat Rev Cancer 2010; 10:267 - 77; http://dx.doi.org/10.1038/nrc2817; PMID: 20300106
   PubMed Web of Science ®Google Scholar
• Fischer CP, Bode BP, Souba WW. Adaptive alterations in cellular metabolism with malignant transformation. Ann Surg 1998; 227:627 - 34, discussion 634-6; http://dx.doi.org/10.1097/00000658-199805000-00003; PMID: 9605654
   PubMed Web of Science ®Google Scholar
• Sandulache VC, Ow TJ, Pickering CR, Frederick MJ, Zhou G, Fokt I, et al. Glucose, not glutamine, is the dominant energy source required for proliferation and survival of head and neck squamous carcinoma cells. Cancer 2011; 117:2926 - 38; http://dx.doi.org/10.1002/cncr.25868; PMID: 21692052
   PubMed Web of Science ®Google Scholar
• DeBerardinis RJ, Cheng T. Q’s next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene 2010; 29:313 - 24; http://dx.doi.org/10.1038/onc.2009.358; PMID: 19881548
   PubMed Web of Science ®Google Scholar
• Meng M, Chen S, Lao T, Liang D, Sang N. Nitrogen anabolism underlies the importance of glutaminolysis in proliferating cells. Cell Cycle 2010; 9:3921 - 32; http://dx.doi.org/10.4161/cc.9.19.13139; PMID: 20935507
   PubMed Web of Science ®Google Scholar
• Matés JM, Pérez-Gómez C, Núñez de Castro I, Asenjo M, Márquez J. Glutamine and its relationship with intracellular redox status, oxidative stress and cell proliferation/death. Int J Biochem Cell Biol 2002; 34:439 - 58; http://dx.doi.org/10.1016/S1357-2725(01)00143-1; PMID: 11906817
   PubMed Web of Science ®Google Scholar
• Backos DS, Franklin CC, Reigan P. The role of glutathione in brain tumor drug resistance. Biochem Pharmacol.
   Google Scholar
• Elgadi KM, Meguid RA, Qian M, Souba WW, Abcouwer SF. Cloning and analysis of unique human glutaminase isoforms generated by tissue-specific alternative splicing. Physiol Genomics 1999; 1:51 - 62; PMID: 11015561
   PubMed Web of Science ®Google Scholar
• Perera SY, Chen TC, Curthoys NP. Biosynthesis and processing of renal mitochondrial glutaminase in cultured proximal tubular epithelial cells and in isolated mitochondria. J Biol Chem 1990; 265:17764 - 70; PMID: 2211660
   PubMed Web of Science ®Google Scholar
• Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T, et al. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 2009; 458:762 - 5; http://dx.doi.org/10.1038/nature07823; PMID: 19219026
   PubMed Web of Science ®Google Scholar
• Wise DR, DeBerardinis RJ, Mancuso A, Sayed N, Zhang XY, Pfeiffer HK, et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc Natl Acad Sci U S A 2008; 105:18782 - 7; http://dx.doi.org/10.1073/pnas.0810199105; PMID: 19033189
   PubMed Web of Science ®Google Scholar
• Weinberg F, Hamanaka R, Wheaton WW, Weinberg S, Joseph J, Lopez M, et al. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc Natl Acad Sci U S A 2010; 107:8788 - 93; http://dx.doi.org/10.1073/pnas.1003428107; PMID: 20421486
   PubMed Web of Science ®Google Scholar
• Wang JB, Erickson JW, Fuji R, Ramachandran S, Gao P, Dinavahi R, et al. Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. Cancer Cell 2010; 18:207 - 19; http://dx.doi.org/10.1016/j.ccr.2010.08.009; PMID: 20832749
   PubMed Web of Science ®Google Scholar
• Seltzer MJ, Bennett BD, Joshi AD, Gao P, Thomas AG, Ferraris DV, et al. Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1. Cancer Res 2010; 70:8981 - 7; http://dx.doi.org/10.1158/0008-5472.CAN-10-1666; PMID: 21045145
   PubMed Web of Science ®Google Scholar
• Lobo C, Ruiz-Bellido MA, Aledo JC, Márquez J, Núñez De Castro I, Alonso FJ. Inhibition of glutaminase expression by antisense mRNA decreases growth and tumourigenicity of tumour cells. Biochem J 2000; 348:257 - 61; http://dx.doi.org/10.1042/0264-6021:3480257; PMID: 10816417
   PubMed Web of Science ®Google Scholar
• Lora J, Alonso FJ, Segura JA, Lobo C, Márquez J, Matés JM. Antisense glutaminase inhibition decreases glutathione antioxidant capacity and increases apoptosis in Ehrlich ascitic tumour cells. Eur J Biochem 2004; 271:4298 - 306; http://dx.doi.org/10.1111/j.1432-1033.2004.04370.x; PMID: 15511236
   PubMedGoogle Scholar
• Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59:225 - 49; http://dx.doi.org/10.3322/caac.20006; PMID: 19474385
   PubMed Web of Science ®Google Scholar
• Greshock J, Bachman KE, Degenhardt YY, Jing J, Wen YH, Eastman S, et al. Molecular target class is predictive of in vitro response profile. Cancer Res 2010; 70:3677 - 86; http://dx.doi.org/10.1158/0008-5472.CAN-09-3788; PMID: 20406975
   PubMed Web of Science ®Google Scholar
• Sanchez-Palencia A, Gomez-Morales M, Gomez-Capilla JA, Pedraza V, Boyero L, Rosell R, et al. Gene expression profiling reveals novel biomarkers in nonsmall cell lung cancer. Int J Cancer 2011; 129:355 - 64; http://dx.doi.org/10.1002/ijc.25704; PMID: 20878980
   PubMed Web of Science ®Google Scholar
• Pinkus LM. Glutamine binding sites. Methods Enzymol 1977; 46:414 - 27; http://dx.doi.org/10.1016/S0076-6879(77)46049-X; PMID: 909432
   PubMedGoogle Scholar
• Robinson MM, McBryant SJ, Tsukamoto T, Rojas C, Ferraris DV, Hamilton SK, et al. Novel mechanism of inhibition of rat kidney-type glutaminase by bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES). Biochem J 2007; 406:407 - 14; http://dx.doi.org/10.1042/BJ20070039; PMID: 17581113
   PubMed Web of Science ®Google Scholar
• Roberg BA, Torgner IA, Kvamme E. Kinetics of a novel isoform of phosphate activated glutaminase (PAG) in SH-SY5Y neuroblastoma cells. Neurochem Res 2010; 35:875 - 80; http://dx.doi.org/10.1007/s11064-009-0077-7; PMID: 19894115
   PubMed Web of Science ®Google Scholar
• Szeliga M, Obara-Michlewska M. Glutamine in neoplastic cells: focus on the expression and roles of glutaminases. Neurochem Int 2009; 55:71 - 5; http://dx.doi.org/10.1016/j.neuint.2009.01.008; PMID: 19428809
   PubMed Web of Science ®Google Scholar
• Szeliga M, Matyja E, Obara M, Grajkowska W, Czernicki T, Albrecht J. Relative expression of mRNAS coding for glutaminase isoforms in CNS tissues and CNS tumors. Neurochem Res 2008; 33:808 - 13; http://dx.doi.org/10.1007/s11064-007-9507-6; PMID: 17940881
   PubMed Web of Science ®Google Scholar
• Porter LD, Ibrahim H, Taylor L, Curthoys NP. Complexity and species variation of the kidney-type glutaminase gene. Physiol Genomics 2002; 9:157 - 66; PMID: 12045296
   PubMed Web of Science ®Google Scholar
• Cassago A, Ferreira AP, Ferreira IM, Fornezari C, Gomes ER, Greene KS, et al. Mitochondrial localization and structure-based phosphate activation mechanism of Glutaminase C with implications for cancer metabolism. Proc Natl Acad Sci U S A 2012; 109:1092 - 7; http://dx.doi.org/10.1073/pnas.1112495109; PMID: 22228304
   PubMed Web of Science ®Google Scholar
• Mazurek S. Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells. Int J Biochem Cell Biol 2011; 43:969 - 80; http://dx.doi.org/10.1016/j.biocel.2010.02.005; PMID: 20156581
   PubMed Web of Science ®Google Scholar
• Yoshioka K, Takehara H, Okada A, Komi N. Glutamine antagonist with diet deficient in glutamine and aspartate reduce tumor growth. Tokushima J Exp Med 1992; 39:69 - 76; PMID: 1412455
   PubMedGoogle Scholar
• Unterluggauer H, Mazurek S, Lener B, Hütter E, Eigenbrodt E, Zwerschke W, et al. Premature senescence of human endothelial cells induced by inhibition of glutaminase. Biogerontology 2008; 9:247 - 59; http://dx.doi.org/10.1007/s10522-008-9134-x; PMID: 18317946
   PubMed Web of Science ®Google Scholar
• Wu F, Lukinius A, Bergström M, Eriksson B, Watanabe Y, Långström B. A mechanism behind the antitumour effect of 6-diazo-5-oxo-L-norleucine (DON): disruption of mitochondria. Eur J Cancer 1999; 35:1155 - 61; http://dx.doi.org/10.1016/S0959-8049(99)00099-4; PMID: 10533463
   PubMed Web of Science ®Google Scholar